We use cookies to ensure that we give you the best experience on our website. By continuing to browse this repository, you give consent for essential cookies to be used. You can read more about our Privacy and Cookie Policy.

Durham Research Online
You are in:

EU Clinical Trials Regulation 2014 : fetter or facilitator?

Cave, Emma (2018) 'EU Clinical Trials Regulation 2014 : fetter or facilitator?', Medical law international., 18 (2-3). pp. 179-194.


European Union (EU) Clinical Trials Regulation 536/2014, expected to come into force in 2019, provides for a streamlined single EU application for cross-border clinical trials and enhanced transparency of results. The status of the Regulation in post-Brexit UK is uncertain. Matters of regulatory alignment will be covered by agreements on the future EU-UK relationship. In the short term, implementation of the Regulation in the United Kingdom depends on the Brexit model and timing of the Regulation’s implementation. The EU (Withdrawal) Act will convert EU law into UK law, including the vast array of EU life sciences regulation. However, the Regulation is likely to be implemented after the United Kingdom leaves the EU, but within the transition period. If the United Kingdom is not part of the legal framework governing clinical trials in the EU, then the United Kingdom will still need to comply with the global framework set out in the International Council on Harmonisation if it wants to be part of trials of medicinal products for which marketing authorization will be sought for licensing in the European Economic Area. This article extols the virtues of harmonization with the EU and attempts to counter some of the media focus on the advantages of a deregulated bespoke approach.

Item Type:Article
Keywords:Clinical trials, Brexit.
Full text:(VoR) Version of Record
Available under License - Creative Commons Attribution Non-commercial.
Download PDF (Advance online version)
Full text:(VoR) Version of Record
Available under License - Creative Commons Attribution Non-commercial.
Download PDF (Final published version)
Publisher Web site:
Publisher statement:This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License ( which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (
Date accepted:23 May 2018
Date deposited:13 September 2018
Date of first online publication:09 September 2018
Date first made open access:No date available

Save or Share this output

Look up in GoogleScholar